Medicaid Tobacco And Nicotine Cessation Treatment Rates Remained Low, 2019-24.

Tobacco use drives large health and fiscal costs for Medicaid, yet few enrollees who use these products receive cessation pharmacotherapy. We estimated that 10.4 percent of daily tobacco or nicotine users received cessation medications in 2024, and Medicaid programs spent $137.6 million on such treatments that year. State-level treatment rates ranged from 1.3 percent to 26.6 percent.